Digital Health Startups

Alnu Health offers a patient companion app and clinician platform that supports GLP-1 therapy patients between visits with clinically backed guidance, lifestyle reinforcement, and escalation visibility. It serves weight management clinics and larger healthcare system programs, aiming to improve treatment adherence while reducing administrative burden on care teams.

1 investor

Alo Solutions provides capital investment and practice transition support services for independent physicians seeking to expand their practices, plan for succession, or transition their patient panels. The company offers tailored financing options and operates the Avance Care platform to help physician-owners optimize their practices and plan for sustainable futures.

1 investor

Aloe Health matches individuals to health insurance plans based on their doctors, medications, family, and preferences, comparing options across thousands of plans to find the best price. It presents personalized plan recommendations rather than generic group coverage.

1 investor

Alper Seguros is a Brazilian insurance brokerage that manages corporate insurance programs and employee benefits for business clients, administering billions of reais in premiums across health, vehicle, and corporate coverage. It also operates digital platforms including Dr. Alper, a telehealth service offering medical, psychological, and nutrition consultations to covered employees.

1 investor

Alpha Cognition develops ZUNVEYL (benzgalantamine), a cholinesterase inhibitor approved for treating mild to moderate dementia of the Alzheimer's type in adults. The company operates in the pharmaceutical sector focused on central nervous system and neurodegenerative disease therapeutics.

1 investor

Physight develops Panorama, a platform that transforms clinical care data into structured, research-ready datasets for healthcare organizations. The system collects and organizes patient data at the point of care to eliminate redundant data entry and enable use for both clinical practice and medical research.

1 investor

Alpinasana develops foods for special medical purposes (medical nutrition products such as drink meals, ice cream, soups and baked goods) alongside an automated nutrition-tracking scanner that logs patients' food intake into hospital information systems. It targets hospitals and care homes in Switzerland to detect and address malnutrition among patients and elderly residents.

1 investor

AlpineAI builds AI software for highly regulated Swiss institutions, offering an all-in-one platform that automates documentation and routine tasks such as generating medical reports, handling administrative casework, and supporting university research. Its products run on Swiss servers under Swiss law, serving healthcare providers, government bodies, and higher education in Switzerland.

1 investor

Alsteni Medical develops an intraoral gastrointestinal access device designed to deliver nutrient therapy for metabolic management. The company is advancing the device through FDA 510(k) clearance with clinical evidence and manufacturing partnerships in place.

1 investor

AlterDiag is a diagnostics company founded by executives with backgrounds in immunology R&D and business strategy. The page focuses on the founding team and does not detail the specific product beyond its work in the diagnostics market.

1 investor

Alto Pax provides a confidentiality-first group therapy platform that connects patients with specialized mental health clinicians, addressing the shortage of care access through measurement-based group care models rather than traditional 1:1 therapy.

1 investor

Altruix operates local, independent pharmacies in the mid-Atlantic region, offering person-centered pharmacy services that specialize in behavioral health, intellectual and developmental disabilities, and substance use disorder. It focuses on helping people access and adhere to their prescribed treatments.

1 investor

Altum Sequencing develops ultra-sensitive, tumor-informed liquid biopsy (ctDNA) tests paired with an AI-driven platform to detect cancer relapse and measure treatment response at the molecular level. It serves clinicians and researchers in oncology and hematology, covering both hematologic malignancies and solid tumors.

1 investor

AlveoGene develops respiratory gene therapies, led by executives and academic researchers from the UK Respiratory Gene Therapy Consortium.

1 investor

Alveos builds a chest-worn wearable that uses patented ACM-sensor technology to measure breathing and heart activity directly, tracking how a user's physiological state changes through the day. It offers short guided routines for calm, focus, energy, and sleep, with real-time haptic feedback and check-ins so the device learns which routines work for the individual.

1 investor

Always Best Care provides in-home senior care, assisted living and senior community referral services, and skilled nursing care for seniors and people with special needs. It also offers specialized health monitoring technology and assistance for veterans navigating VA financing, serving families across the U.S. and Canada.

1 investor

Alyf develops AI-native heart care technology built by physicians to surface hidden cardiac signals and guide clinical action. The platform is currently deployed with leading medical centers and expanding access through 2026-2027.

1 investor

Alzinova is a clinical-stage biopharmaceutical company developing an active immunotherapy (vaccine) for Alzheimer's disease based on its proprietary AβCC Peptide technology. The company's lead candidate is in clinical testing in patients, and its shares are listed on Nasdaq First North Growth Market in Stockholm.

1 investor

American-Sino (美华) operates private hospitals and clinics in Shanghai, including a women's and children's hospital, medical centers, pediatric and maternity care facilities. It provides medical services across departments such as obstetrics and gynecology, pediatrics, dermatology, dentistry, traditional Chinese medicine, and general practice.

1 investor

Amaha is a mental healthcare provider in India offering therapy, psychiatry, hospital care, child and youth services, a moderated support community, and a self-help app for individuals, families, and organisations. It operates in-person centres across Bangalore, Mumbai, and Delhi alongside online care, serving people of all ages in 15+ Indian languages.

1 investor

Amaron develops an Enterprise Application Integration platform that enables healthcare organizations to exchange data seamlessly between their systems and devices using Mirth Connect and open standards like HL7, FHIR, and DICOM.

1 investor

Amaros builds AmarosEngine, a precision intelligence platform that integrates ophthalmology clinics' EHR, practice management, and imaging systems to unify ophthalmic data and generate real-world evidence and insights. It serves CROs, pharma, biotech, and eye-care clinics across the ophthalmic ecosystem for clinical trials, point-of-care treatment, and commercial growth, primarily in the United States with global expansion.

1 investor

Amayu operates a platform in Germany that connects patients with ketamine therapy for psychiatric and chronic conditions, combining medical ketamine treatments delivered by independent partner physicians with accompanying psychological support. It coordinates in-practice sessions and online video consultations for conditions such as depression, anxiety, trauma, OCD, chronic pain, and addiction, currently offering treatment in Berlin with planned expansion to other German cities.

1 investor

Amblea operates a platform that centralizes and optimizes medical transport, connecting healthcare facilities (hospitals, clinics, EHPADs) with ambulance companies and licensed taxis for transfers, outpatient visits, and home returns. It offers dematerialized prescriptions, traceability, automated billing, and shared-ride trip optimization, and is deployed in over 800 facilities in France.

1 investor